A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Inclusion Criteria

• Diagnosis of platinum resistant or refractory OVCA having received 2 or fewer prior lines, or recurrent advanced NSCLC having received 3 or fewer prior lines
• Performance Status of 0, 1, or 2
• Adequate bone marrow, kidney, and liver function Q2W

Exclusion Criteria

• OVCA pts excluded with any of the following: non-epithelial, including malignant mixed mullerian tumors, unresolved bowel obstruction
• Brain metastases requiring steroids
• Major surgery, radiation therapy, or systemic anti-cancer therapy within 4 weeks of study treatment start
• Active and clinically significant bacterial, fungal, or viral infection Q3W